Role of Cytoplasmic Tail of the Type 1A Angiotensin II Receptor in Agonist- and Phorbol Ester-Induced Desensitization
To investigate mechanisms underlying the agonist-induced desensitization of the type 1A angiotensin II receptor (AT1A-R), we have stably expressed in Chinese hamster ovary (CHO) cells the wild-type receptor and truncated mutants lacking varying lengths of the cytoplasmic tail. Assay of inositol 1,4,...
Gespeichert in:
Veröffentlicht in: | Circulation research 1998-03, Vol.82 (5), p.523-531 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 531 |
---|---|
container_issue | 5 |
container_start_page | 523 |
container_title | Circulation research |
container_volume | 82 |
creator | Tang, Hua Guo, Deng Fu Porter, James P Wanaka, Yoshio Inagami, Tadashi |
description | To investigate mechanisms underlying the agonist-induced desensitization of the type 1A angiotensin II receptor (AT1A-R), we have stably expressed in Chinese hamster ovary (CHO) cells the wild-type receptor and truncated mutants lacking varying lengths of the cytoplasmic tail. Assay of inositol 1,4,5-trisphosphate (IP (3)) formation in response to agonist demonstrated that the truncated mutants T318, T328, and T348 lacking the last 42, 32, or 12 amino acid residues, respectively, couple with Gq protein with an efficiency similar to that of full-length receptors, whereas coupling of Gq protein was abolished in the T310 truncated mutant devoid of the carboxyl-terminal 50 amino acids. Exposure of CHO/AT1A-R cells expressing the wild-type AT1A-R to angiotensin II resulted in rapid and dose-dependent homologous desensitization of receptor-mediated IP3 formation, which was independent of the receptor internalization. Mastoparan, an activator of G protein-coupled receptor kinase (GRK), induced desensitization of the AT1A-R. The agonist-induced desensitization of the receptor was largely prevented by heparin, a potent inhibitor of GRK, whereas it was only partially attenuated by a protein kinase C (PKC)-specific inhibitor. The homologous or heterologous desensitization of the receptor was greatly impaired in the truncated mutants T318 and T328, lacking the Ser/Thr-rich (13 or 12 Ser/Thr residues) cytoplasmic tail of the AT1A-R. Deletion of the last two Ser residues, including one PKC consensus site in the receptor tail, prevented only phorbol 12-myristate 13-acetate-induced desensitization by 30%. Moreover, we found an agonist-induced translocation of a heparin-sensitive kinase activity. The angiotensin II-stimulated heparin-sensitive kinase could phosphorylate a thioredoxin fusion protein containing the entire AT1A-R cytoplasmic tail (N to E), which lacks consensus phosphorylation sites for GRK1, GRK2, and GRK3. The heparin-sensitive kinase may not be GRK2, GRK3, or GRK6 expressed in CHO/AT1A-R cells, since angiotensin II did not induce translocation of these receptor kinases. Potential Ser/Thr phosphorylation sites located between S and S in the cytoplasmic tail of AT1A-R seem to play a critical role in the heterologous and homologous desensitization of the receptor. A heparin-sensitive kinase other than GRK2, GRK3, or GRK6 may be involved in the agonist-induced homologous desensitization of the AT1A-R. (Circ Res. 1998;82:523-531.) |
doi_str_mv | 10.1161/01.res.82.5.523 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_212414679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>27789918</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4511-3c21835124bb15706cfc7f85b6a96f0b94388cd54e9399ee692b6eddcb46e5b13</originalsourceid><addsrcrecordid>eNo9kUGP0zAQhS0EWsrCmROShbgm67FjNz5W3QKVVgKVcrYcZ7LNksbBdrQqvx5XrfY0mnnfvJHeEPIRWAmg4I5BGTCWNS9lKbl4RRYgeVVUcgmvyYIxpoulEOwteRfjE2NQCa5vyI2WXINUCzLv_IDUd3R9Sn4abDz2ju5tP5xn6YB0f5qQwoquxsfeJxxjP9Ltlu7Q4ZR8oLldPfqxj6mgdmzpz4MPjR_oJiYMxXZsZ4ctvcd4Xk39P5t6P74nbzo7RPxwrbfk99fNfv29ePjxbbtePRSukgCFcBxqIYFXTQNyyZTr3LKrZaOsVh1rdCXq2rWyQi20RlSaNwrb1jWVQtmAuCWfL75T8H9njMk8-TmM-aTh2RUqtdQZurtALvgYA3ZmCv3RhpMBZs4hGwZmt_llam6kySHnjU9X27k5YvvCX1PN-perbqOzQxfs6Pr4gnHOlBY8Y9UFe_ZDDiv-GeZnDOaAdkgHk3_HBANegNY1yzgrziMQ_wFl8pNo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212414679</pqid></control><display><type>article</type><title>Role of Cytoplasmic Tail of the Type 1A Angiotensin II Receptor in Agonist- and Phorbol Ester-Induced Desensitization</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Tang, Hua ; Guo, Deng Fu ; Porter, James P ; Wanaka, Yoshio ; Inagami, Tadashi</creator><creatorcontrib>Tang, Hua ; Guo, Deng Fu ; Porter, James P ; Wanaka, Yoshio ; Inagami, Tadashi</creatorcontrib><description>To investigate mechanisms underlying the agonist-induced desensitization of the type 1A angiotensin II receptor (AT1A-R), we have stably expressed in Chinese hamster ovary (CHO) cells the wild-type receptor and truncated mutants lacking varying lengths of the cytoplasmic tail. Assay of inositol 1,4,5-trisphosphate (IP (3)) formation in response to agonist demonstrated that the truncated mutants T318, T328, and T348 lacking the last 42, 32, or 12 amino acid residues, respectively, couple with Gq protein with an efficiency similar to that of full-length receptors, whereas coupling of Gq protein was abolished in the T310 truncated mutant devoid of the carboxyl-terminal 50 amino acids. Exposure of CHO/AT1A-R cells expressing the wild-type AT1A-R to angiotensin II resulted in rapid and dose-dependent homologous desensitization of receptor-mediated IP3 formation, which was independent of the receptor internalization. Mastoparan, an activator of G protein-coupled receptor kinase (GRK), induced desensitization of the AT1A-R. The agonist-induced desensitization of the receptor was largely prevented by heparin, a potent inhibitor of GRK, whereas it was only partially attenuated by a protein kinase C (PKC)-specific inhibitor. The homologous or heterologous desensitization of the receptor was greatly impaired in the truncated mutants T318 and T328, lacking the Ser/Thr-rich (13 or 12 Ser/Thr residues) cytoplasmic tail of the AT1A-R. Deletion of the last two Ser residues, including one PKC consensus site in the receptor tail, prevented only phorbol 12-myristate 13-acetate-induced desensitization by 30%. Moreover, we found an agonist-induced translocation of a heparin-sensitive kinase activity. The angiotensin II-stimulated heparin-sensitive kinase could phosphorylate a thioredoxin fusion protein containing the entire AT1A-R cytoplasmic tail (N to E), which lacks consensus phosphorylation sites for GRK1, GRK2, and GRK3. The heparin-sensitive kinase may not be GRK2, GRK3, or GRK6 expressed in CHO/AT1A-R cells, since angiotensin II did not induce translocation of these receptor kinases. Potential Ser/Thr phosphorylation sites located between S and S in the cytoplasmic tail of AT1A-R seem to play a critical role in the heterologous and homologous desensitization of the receptor. A heparin-sensitive kinase other than GRK2, GRK3, or GRK6 may be involved in the agonist-induced homologous desensitization of the AT1A-R. (Circ Res. 1998;82:523-531.)</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/01.res.82.5.523</identifier><identifier>PMID: 9529156</identifier><identifier>CODEN: CIRUAL</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>Amino Acid Sequence ; Animals ; beta-Adrenergic Receptor Kinases ; Biological and medical sciences ; Carcinogens - pharmacology ; Cell receptors ; Cell structures and functions ; CHO Cells - chemistry ; CHO Cells - enzymology ; Cricetinae ; Cyclic AMP-Dependent Protein Kinases - metabolism ; Fundamental and applied biological sciences. Psychology ; G-Protein-Coupled Receptor Kinase 3 ; G-Protein-Coupled Receptor Kinases ; GTP-Binding Proteins - physiology ; Hormone receptors. Growth factor receptors. Cytokine receptors. Prostaglandin receptors ; Inositol 1,4,5-Trisphosphate - metabolism ; Ion Channel Gating - drug effects ; Molecular and cellular biology ; Molecular Sequence Data ; Mutagenesis - physiology ; Phosphorylation ; Protein Structure, Tertiary ; Protein-Serine-Threonine Kinases - physiology ; Rats ; Receptor Protein-Tyrosine Kinases - metabolism ; Receptors, Angiotensin - agonists ; Receptors, Angiotensin - chemistry ; Receptors, Angiotensin - genetics ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - metabolism ; Tetradecanoylphorbol Acetate - pharmacology ; Thioredoxins - genetics ; Thioredoxins - metabolism</subject><ispartof>Circulation research, 1998-03, Vol.82 (5), p.523-531</ispartof><rights>1998 American Heart Association, Inc.</rights><rights>1998 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Mar 23, 1998</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4511-3c21835124bb15706cfc7f85b6a96f0b94388cd54e9399ee692b6eddcb46e5b13</citedby><cites>FETCH-LOGICAL-c4511-3c21835124bb15706cfc7f85b6a96f0b94388cd54e9399ee692b6eddcb46e5b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2206932$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9529156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Hua</creatorcontrib><creatorcontrib>Guo, Deng Fu</creatorcontrib><creatorcontrib>Porter, James P</creatorcontrib><creatorcontrib>Wanaka, Yoshio</creatorcontrib><creatorcontrib>Inagami, Tadashi</creatorcontrib><title>Role of Cytoplasmic Tail of the Type 1A Angiotensin II Receptor in Agonist- and Phorbol Ester-Induced Desensitization</title><title>Circulation research</title><addtitle>Circ Res</addtitle><description>To investigate mechanisms underlying the agonist-induced desensitization of the type 1A angiotensin II receptor (AT1A-R), we have stably expressed in Chinese hamster ovary (CHO) cells the wild-type receptor and truncated mutants lacking varying lengths of the cytoplasmic tail. Assay of inositol 1,4,5-trisphosphate (IP (3)) formation in response to agonist demonstrated that the truncated mutants T318, T328, and T348 lacking the last 42, 32, or 12 amino acid residues, respectively, couple with Gq protein with an efficiency similar to that of full-length receptors, whereas coupling of Gq protein was abolished in the T310 truncated mutant devoid of the carboxyl-terminal 50 amino acids. Exposure of CHO/AT1A-R cells expressing the wild-type AT1A-R to angiotensin II resulted in rapid and dose-dependent homologous desensitization of receptor-mediated IP3 formation, which was independent of the receptor internalization. Mastoparan, an activator of G protein-coupled receptor kinase (GRK), induced desensitization of the AT1A-R. The agonist-induced desensitization of the receptor was largely prevented by heparin, a potent inhibitor of GRK, whereas it was only partially attenuated by a protein kinase C (PKC)-specific inhibitor. The homologous or heterologous desensitization of the receptor was greatly impaired in the truncated mutants T318 and T328, lacking the Ser/Thr-rich (13 or 12 Ser/Thr residues) cytoplasmic tail of the AT1A-R. Deletion of the last two Ser residues, including one PKC consensus site in the receptor tail, prevented only phorbol 12-myristate 13-acetate-induced desensitization by 30%. Moreover, we found an agonist-induced translocation of a heparin-sensitive kinase activity. The angiotensin II-stimulated heparin-sensitive kinase could phosphorylate a thioredoxin fusion protein containing the entire AT1A-R cytoplasmic tail (N to E), which lacks consensus phosphorylation sites for GRK1, GRK2, and GRK3. The heparin-sensitive kinase may not be GRK2, GRK3, or GRK6 expressed in CHO/AT1A-R cells, since angiotensin II did not induce translocation of these receptor kinases. Potential Ser/Thr phosphorylation sites located between S and S in the cytoplasmic tail of AT1A-R seem to play a critical role in the heterologous and homologous desensitization of the receptor. A heparin-sensitive kinase other than GRK2, GRK3, or GRK6 may be involved in the agonist-induced homologous desensitization of the AT1A-R. (Circ Res. 1998;82:523-531.)</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>beta-Adrenergic Receptor Kinases</subject><subject>Biological and medical sciences</subject><subject>Carcinogens - pharmacology</subject><subject>Cell receptors</subject><subject>Cell structures and functions</subject><subject>CHO Cells - chemistry</subject><subject>CHO Cells - enzymology</subject><subject>Cricetinae</subject><subject>Cyclic AMP-Dependent Protein Kinases - metabolism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>G-Protein-Coupled Receptor Kinase 3</subject><subject>G-Protein-Coupled Receptor Kinases</subject><subject>GTP-Binding Proteins - physiology</subject><subject>Hormone receptors. Growth factor receptors. Cytokine receptors. Prostaglandin receptors</subject><subject>Inositol 1,4,5-Trisphosphate - metabolism</subject><subject>Ion Channel Gating - drug effects</subject><subject>Molecular and cellular biology</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis - physiology</subject><subject>Phosphorylation</subject><subject>Protein Structure, Tertiary</subject><subject>Protein-Serine-Threonine Kinases - physiology</subject><subject>Rats</subject><subject>Receptor Protein-Tyrosine Kinases - metabolism</subject><subject>Receptors, Angiotensin - agonists</subject><subject>Receptors, Angiotensin - chemistry</subject><subject>Receptors, Angiotensin - genetics</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Thioredoxins - genetics</subject><subject>Thioredoxins - metabolism</subject><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kUGP0zAQhS0EWsrCmROShbgm67FjNz5W3QKVVgKVcrYcZ7LNksbBdrQqvx5XrfY0mnnfvJHeEPIRWAmg4I5BGTCWNS9lKbl4RRYgeVVUcgmvyYIxpoulEOwteRfjE2NQCa5vyI2WXINUCzLv_IDUd3R9Sn4abDz2ju5tP5xn6YB0f5qQwoquxsfeJxxjP9Ltlu7Q4ZR8oLldPfqxj6mgdmzpz4MPjR_oJiYMxXZsZ4ctvcd4Xk39P5t6P74nbzo7RPxwrbfk99fNfv29ePjxbbtePRSukgCFcBxqIYFXTQNyyZTr3LKrZaOsVh1rdCXq2rWyQi20RlSaNwrb1jWVQtmAuCWfL75T8H9njMk8-TmM-aTh2RUqtdQZurtALvgYA3ZmCv3RhpMBZs4hGwZmt_llam6kySHnjU9X27k5YvvCX1PN-perbqOzQxfs6Pr4gnHOlBY8Y9UFe_ZDDiv-GeZnDOaAdkgHk3_HBANegNY1yzgrziMQ_wFl8pNo</recordid><startdate>19980323</startdate><enddate>19980323</enddate><creator>Tang, Hua</creator><creator>Guo, Deng Fu</creator><creator>Porter, James P</creator><creator>Wanaka, Yoshio</creator><creator>Inagami, Tadashi</creator><general>American Heart Association, Inc</general><general>Lippincott</general><general>Lippincott Williams & Wilkins Ovid Technologies</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>19980323</creationdate><title>Role of Cytoplasmic Tail of the Type 1A Angiotensin II Receptor in Agonist- and Phorbol Ester-Induced Desensitization</title><author>Tang, Hua ; Guo, Deng Fu ; Porter, James P ; Wanaka, Yoshio ; Inagami, Tadashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4511-3c21835124bb15706cfc7f85b6a96f0b94388cd54e9399ee692b6eddcb46e5b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>beta-Adrenergic Receptor Kinases</topic><topic>Biological and medical sciences</topic><topic>Carcinogens - pharmacology</topic><topic>Cell receptors</topic><topic>Cell structures and functions</topic><topic>CHO Cells - chemistry</topic><topic>CHO Cells - enzymology</topic><topic>Cricetinae</topic><topic>Cyclic AMP-Dependent Protein Kinases - metabolism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>G-Protein-Coupled Receptor Kinase 3</topic><topic>G-Protein-Coupled Receptor Kinases</topic><topic>GTP-Binding Proteins - physiology</topic><topic>Hormone receptors. Growth factor receptors. Cytokine receptors. Prostaglandin receptors</topic><topic>Inositol 1,4,5-Trisphosphate - metabolism</topic><topic>Ion Channel Gating - drug effects</topic><topic>Molecular and cellular biology</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis - physiology</topic><topic>Phosphorylation</topic><topic>Protein Structure, Tertiary</topic><topic>Protein-Serine-Threonine Kinases - physiology</topic><topic>Rats</topic><topic>Receptor Protein-Tyrosine Kinases - metabolism</topic><topic>Receptors, Angiotensin - agonists</topic><topic>Receptors, Angiotensin - chemistry</topic><topic>Receptors, Angiotensin - genetics</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Thioredoxins - genetics</topic><topic>Thioredoxins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Hua</creatorcontrib><creatorcontrib>Guo, Deng Fu</creatorcontrib><creatorcontrib>Porter, James P</creatorcontrib><creatorcontrib>Wanaka, Yoshio</creatorcontrib><creatorcontrib>Inagami, Tadashi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Hua</au><au>Guo, Deng Fu</au><au>Porter, James P</au><au>Wanaka, Yoshio</au><au>Inagami, Tadashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Cytoplasmic Tail of the Type 1A Angiotensin II Receptor in Agonist- and Phorbol Ester-Induced Desensitization</atitle><jtitle>Circulation research</jtitle><addtitle>Circ Res</addtitle><date>1998-03-23</date><risdate>1998</risdate><volume>82</volume><issue>5</issue><spage>523</spage><epage>531</epage><pages>523-531</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><coden>CIRUAL</coden><abstract>To investigate mechanisms underlying the agonist-induced desensitization of the type 1A angiotensin II receptor (AT1A-R), we have stably expressed in Chinese hamster ovary (CHO) cells the wild-type receptor and truncated mutants lacking varying lengths of the cytoplasmic tail. Assay of inositol 1,4,5-trisphosphate (IP (3)) formation in response to agonist demonstrated that the truncated mutants T318, T328, and T348 lacking the last 42, 32, or 12 amino acid residues, respectively, couple with Gq protein with an efficiency similar to that of full-length receptors, whereas coupling of Gq protein was abolished in the T310 truncated mutant devoid of the carboxyl-terminal 50 amino acids. Exposure of CHO/AT1A-R cells expressing the wild-type AT1A-R to angiotensin II resulted in rapid and dose-dependent homologous desensitization of receptor-mediated IP3 formation, which was independent of the receptor internalization. Mastoparan, an activator of G protein-coupled receptor kinase (GRK), induced desensitization of the AT1A-R. The agonist-induced desensitization of the receptor was largely prevented by heparin, a potent inhibitor of GRK, whereas it was only partially attenuated by a protein kinase C (PKC)-specific inhibitor. The homologous or heterologous desensitization of the receptor was greatly impaired in the truncated mutants T318 and T328, lacking the Ser/Thr-rich (13 or 12 Ser/Thr residues) cytoplasmic tail of the AT1A-R. Deletion of the last two Ser residues, including one PKC consensus site in the receptor tail, prevented only phorbol 12-myristate 13-acetate-induced desensitization by 30%. Moreover, we found an agonist-induced translocation of a heparin-sensitive kinase activity. The angiotensin II-stimulated heparin-sensitive kinase could phosphorylate a thioredoxin fusion protein containing the entire AT1A-R cytoplasmic tail (N to E), which lacks consensus phosphorylation sites for GRK1, GRK2, and GRK3. The heparin-sensitive kinase may not be GRK2, GRK3, or GRK6 expressed in CHO/AT1A-R cells, since angiotensin II did not induce translocation of these receptor kinases. Potential Ser/Thr phosphorylation sites located between S and S in the cytoplasmic tail of AT1A-R seem to play a critical role in the heterologous and homologous desensitization of the receptor. A heparin-sensitive kinase other than GRK2, GRK3, or GRK6 may be involved in the agonist-induced homologous desensitization of the AT1A-R. (Circ Res. 1998;82:523-531.)</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>9529156</pmid><doi>10.1161/01.res.82.5.523</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7330 |
ispartof | Circulation research, 1998-03, Vol.82 (5), p.523-531 |
issn | 0009-7330 1524-4571 |
language | eng |
recordid | cdi_proquest_journals_212414679 |
source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
subjects | Amino Acid Sequence Animals beta-Adrenergic Receptor Kinases Biological and medical sciences Carcinogens - pharmacology Cell receptors Cell structures and functions CHO Cells - chemistry CHO Cells - enzymology Cricetinae Cyclic AMP-Dependent Protein Kinases - metabolism Fundamental and applied biological sciences. Psychology G-Protein-Coupled Receptor Kinase 3 G-Protein-Coupled Receptor Kinases GTP-Binding Proteins - physiology Hormone receptors. Growth factor receptors. Cytokine receptors. Prostaglandin receptors Inositol 1,4,5-Trisphosphate - metabolism Ion Channel Gating - drug effects Molecular and cellular biology Molecular Sequence Data Mutagenesis - physiology Phosphorylation Protein Structure, Tertiary Protein-Serine-Threonine Kinases - physiology Rats Receptor Protein-Tyrosine Kinases - metabolism Receptors, Angiotensin - agonists Receptors, Angiotensin - chemistry Receptors, Angiotensin - genetics Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - metabolism Tetradecanoylphorbol Acetate - pharmacology Thioredoxins - genetics Thioredoxins - metabolism |
title | Role of Cytoplasmic Tail of the Type 1A Angiotensin II Receptor in Agonist- and Phorbol Ester-Induced Desensitization |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T14%3A13%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Cytoplasmic%20Tail%20of%20the%20Type%201A%20Angiotensin%20II%20Receptor%20in%20Agonist-%20and%20Phorbol%20Ester-Induced%20Desensitization&rft.jtitle=Circulation%20research&rft.au=Tang,%20Hua&rft.date=1998-03-23&rft.volume=82&rft.issue=5&rft.spage=523&rft.epage=531&rft.pages=523-531&rft.issn=0009-7330&rft.eissn=1524-4571&rft.coden=CIRUAL&rft_id=info:doi/10.1161/01.res.82.5.523&rft_dat=%3Cproquest_cross%3E27789918%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=212414679&rft_id=info:pmid/9529156&rfr_iscdi=true |